Title : Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.

Pub. Date : 2020

PMID : 32390596






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma. Sorafenib aurora kinase A Homo sapiens
2 Furthermore, the concomitant high expression of FOXM1 and Aurora-A predicted the worst OS of sorafenib-treated patients with HCC. Sorafenib aurora kinase A Homo sapiens
3 CONCLUSIONS: The co-expression of FOXM1 and Aurora-A could be a reliable biomarker to predict the sorafenib response and prognosis of HCC patients. Sorafenib aurora kinase A Homo sapiens